GORE VIABAHN Endoprosthesis with Heparin VBHR070502ARecalls & reported problems
W. L. Gore & Associates, Inc. · VIABAHN SX ENDO HEPARIN 35 RO 7mmX5cm 8Fr 120cmCath · Class 3 · Implant
All models of GORE VIABAHN Endoprosthesis with Heparin (62)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00733132622948), received between Nov 13, 2024 and Mar 24, 2025 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 24, 2025Break; Break
ON (B)(6) 2025, A PATIENT WITH BILATERAL LOWER-LIMB BYPASS GRAFTS, UNDERWENT LEFT LEG BYPASS REVISION (BRAND OF GRAFTS AND DATE OF INITIAL IMPLANT UNKNOWN). IT WAS REPORTED THE PATIENT DID NOT TAKE ANTICOAGULANT MEDICATION FOR AT LEAST 12 DAYS. ON (B)(6) 2025, THE PATIENT PRESENTED WITH LOWER LIMB THREATENING ISCHEMIA OF UNKNOWN DURATION. IT WAS NOTED THERE WAS THROMBOSIS IN THE LEFT FEMORAL-TIBIAL BYPASS ARTERY BYPASS GRAFT, AND SEVERE STENOSIS IN THE LEFT EXTERNAL ILIAC ARTERY. THE DECISION WAS MADE TO USE A 7 MM X 5 CM GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE (VIABAHN DEVICE) IN THE SEVERELY STENOSED LEFT EXTERNAL ILIAC ARTERY. IT WAS REPORTED, THE LESION IN THE EXTERNAL ILIAC ARTERY WAS PRE-DILATED WITH A 6 MM X 60 MM ARMADA BALLOON. THE PHYSICIAN ACCESSED THE PATIENT USING A 10 F UNKNOWN BRAND INTRODUCER SHEATH OVER AN .035" TERUMO ADVANTAGE GUIDE WIRE (180 CM) TO THE TARGET TREATMENT SITE. REPORTEDLY, THE ENDOPROSTHESIS DEPLOYED. AFTER WITHDRAWAL OF THE DELIVERY SYSTEM CATHETER, IT WAS NOTICED THE DISTAL SECTION OF THE CATHETER WAS RETAINED INSIDE THE PATIENT. THE CASE WAS EXTENDED BY APPROXIMATELY 30 - 40 MINUTES AND ADDITIONAL HEPARIN WAS UTILIZED. THE B
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21678264 ↗MalfunctionNov 13, 2024
SCRUB TECH FLUSHED STENT AND SAW THAT IT WAS LEAKING AROUND SEAL THAT IS USED TO DEPLOY STENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20673652 ↗
Other System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment devices
- COVERA AVSM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall33 reports
- COVERA AVSM08060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall21 reports
- COVERA AVSM09060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall18 reports
- COVERA AVSM10080Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall16 reports
- COVERA AVSM10040Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall15 reports
- COVERA AVFM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall14 reports
- COVERA AVSM09080Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall1 death14 reports
- COVERA AVSM10100Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall13 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page